Investing in Data Quality and Collaboration: The Veeva MedTech Clinical Benchmark 2025 Findings
Insights from the Veeva MedTech Clinical Benchmark 2025
The 2025 Veeva MedTech Clinical Benchmark study recently published by Veeva Systems sheds light on the strategies that medical technology firms are implementing to enhance the efficiency of clinical trials. According to the report, approximately 70% of respondents prioritize collaboration with research sites and improving data quality as essential components in streamlining clinical operations.
The findings indicate a strong commitment among clinical teams to reduce the reliance on manual processes. 68% of surveyed participants stated that minimizing manual tasks is critical for enhancing study quality and achieving better visibility and control over clinical work. This focus on efficiency underscores how technology can facilitate smoother workflows and quicker trial timelines, ultimately benefiting patient access to new treatments.
Key Challenges Identified
The research highlighted several major challenges faced by medical technology companies in managing clinical trial sites. Participants pointed out issues such as timely data entry and quality, document sharing, compliance, and control processes as significant hurdles. Notably, only 14% of companies earning over $1 billion and 24% of those below that threshold currently employ site collaboration tools, revealing a concerning gap in the industry as firms strive to improve trial efficiency and accelerate study timelines.
High-Risk Obstacles
The report pointed out that reliance on manual processes contributes to heightened operational risks. 32% of respondents noted that adherence to global trial regulations and readiness for inspections were among the top barriers to effective clinical operations. These high-risk areas not only escalate operational costs but also lead to significant delays in clinical trials.
Initiatives for Improvement
Despite these challenges, many firms are actively seeking to optimize their processes. Around 58% of respondents plan to prioritize data collection and cleaning over the next year, ensuring trial integrity. This strategic emphasis allows clinical teams to dedicate less time to reconciling data discrepancies and focus their efforts on more high-value trial activities.
Future Trends: AI and Machine Learning Adoption
The study also revealed that a major push towards emerging technologies is underway. Nearly 72% of medical technology organizations are looking to invest in AI and machine learning infrastructure. They aim to harmonize existing systems and standardize data formats to make their data AI-ready. This forward-thinking approach illustrates the industry's commitment to leveraging technology for improved clinical outcomes.
“The medical technology sector is taking proactive measures to advance clinical processes, site collaboration, and data quality despite economic pressures and new regulations,” commented Kevin Liang, vice president of clinical strategy at Veeva MedTech. “The report emphasizes that companies are focused on ensuring data integrity, improving operational efficiency, and establishing connected processes among stakeholders, allowing for quicker access to new technologies for patients.”
Conclusion
The 2025 Veeva MedTech Clinical Benchmark study involved feedback from over 100 clinical professionals within the medical device and diagnostics sectors, exploring the current state of clinical trials and their operational modernization efforts. This insightful report illustrates the ongoing evolution of clinical operations and the pressing need for improved tools and methodologies.
For more in-depth insights, readers are encouraged to access the full report.
About Veeva MedTech
Veeva MedTech is dedicated to helping medical device and diagnostics firms streamline the complete product development and commercialization cycle to bring treatments to patients more effectively. Their offerings include applications that enhance clinical, regulatory, quality, commercial, and medical operations. More details are available at veeva.com/medtech.
About Veeva Systems
Veeva leads the global cloud software market for life sciences and is committed to helping over 1,000 clients, from large biopharmaceutical firms to emerging biotechnology companies, achieve success through innovative solutions. For additional information, please visit veeva.com/eu.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.